Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Comments on “Low-Dose-Rate Prostate Brachytherapy: 4–8 Week Postimplant Prostate-Specific Antigen a Novel Predictor of Biochemical Failure-Free Survival” Publisher Pubmed



Mansori K1, 2 ; Ayubi E3, 4 ; Safiri S5
Authors

Source: Brachytherapy Published:2018


Abstract

[No abstract available]
Other Related Docs